Non-interventional study to collect real-world clinical and patient-reported outcomes in ovarian cancer

Trial Identifier: D0817R00030
Sponsor: AstraZeneca
Collaborator:
North-Eastern German Society of Gynecological Oncology e.V. (NOGGO e.V.)
NCTID:: NCT04830709
Start Date: June 2021
Primary Completion Date: December 2031
Study Completion Date: December 2031
Condition: Ovarian Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations